ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
티카그렐러 시장 규모는 향후 몇 년간 강력한 성장이 예상될 예정입니다. 이러한 성장의 주요 촉진요인은 맞춤형 치료 방법의 통합, 의료비 지출의 급증, 덜 침습적인 치료법의 선호도 증가, 예방적 심장 치료에 대한 강조, 그리고 정부의 심장 건강 지원 프로그램 등입니다. 예측 기간 동안 예상되는 주요 동향으로는 맞춤형 의약품의 발전, 티카그렐러 제네릭 제품의 등장, 의약품 개발에 AI의 활용, 항혈소판 치료의 혁신, 고정 용량 복합 약물을 통한 환자 순응도 개선 추진 등이 있습니다.
심혈관 질환의 유병률 증가는 향후 몇 년 동안 티카그렐러 시장의 성장을 촉진할 것으로 예상됩니다. 심혈관 질환은 관상 동맥 심장 질환, 심부전, 뇌졸중, 고혈압 등 심장과 혈관에 영향을 미치는 다양한 질환을 포함합니다. 이러한 유병률의 증가는 주로 고혈압, 비만, 콜레스테롤 수치 상승의 주요 위험 요인인 포화 지방, 트랜스 지방, 첨가 당, 나트륨의 과다 섭취를 포함한 건강에 해로운 식습관으로 인한 것입니다. 티카그렐러는 혈소판 응집을 방지하여 혈전 위험을 줄임으로써 이러한 질병의 치료에 중요한 역할을 합니다. 특히 고위험군에서 심장 마비 및 뇌졸중의 발생 가능성을 낮춤으로써 환자의 예후를 개선합니다. 예를 들어(2024년) 1월 미국 심장 협회(American Heart Association)는 2022년 심혈관 질환으로 인한 연령 조정 사망률이 10만 명당 233.3명으로 증가했다고 보고했습니다. 이는 2021년 10만 명당 224.4명에서 4.0% 증가한 수치입니다. 이로 인해 심혈관 질환의 증가하는 부담은 티카그렐러 시장 확장을 뒷받침하고 있습니다. .
티카그렐러 시장 주요 기업들은 제품 적응증 확대, 시장 침투율 향상, 경쟁력 강화 등을 위해 규제 승인을 적극적으로 추진하고 있습니다. 규제 승인은 정부 기관으로부터 제품의 판매 및 유통을 공식적으로 허가하는 것으로, 안전성, 유효성, 품질 기준을 충족함을 보장합니다. 예를 들어, 2025년 5월, 인도에 본사를 둔 제약 회사인 Alembic Pharmaceuticals Ltd.는 90mg 용량의 제네릭 티카그렐러 정제에 대해 미국 식품의약국(USFDA)으로부터 약식 신약 신청(ANDA)을 승인받았으며, 60mg 제형에 대해서도 잠정 승인을 받았습니다. 이 정제는 혈소판 응집을 억제하고 혈전 형성을 방지함으로써 심혈관 질환 위험을 감소시키는 목적으로 개발되었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 티카그렐러 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 티카그렐러 시장 : 성장률 분석
세계의 티카그렐러 시장 실적 : 규모와 성장(2019-2024년)
세계의 티카그렐러 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 티카그렐러 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 티카그렐러 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
90mg정
60mg정
세계의 티카그렐러 시장 : 약제 클래스별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
항혈소판제
항혈전제
세계의 티카그렐러 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
세계의 티카그렐러 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
급성관 증후군
심근경색
뇌졸중 예방
기타
세계의 티카그렐러 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 및 진료소
외래센터
기타
세계의 티카그렐러 시장 : 90mg정 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
표준 90mg 티카그렐러정
서방형 90mg 티카그렐러정
세계의 티카그렐러 시장 : 60mg정 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
표준 60mg 티카그렐러정
서방형 60mg 티카그렐러정
제7장 지역 및 국가별 분석
세계의 티카그렐러 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 티카그렐러 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
티카그렐러 시장 : 경쟁 구도
티카그렐러 시장 : 기업 프로파일
AstraZeneca PLC : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
Boehringer Ingelheim International GmbH : 개요, 제품 및 서비스, 전략 및 재무 분석
Sun Pharmaceutical Industries Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
Dr. Reddy's Laboratories Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Cadila Pharmaceuticals Limited
Alkem Laboratories
Alembic Pharmaceuticals Limited
CCL Pharmaceuticals
Neuland Laboratories
Jiangxi Synergy Pharmaceutical Co. Ltd.
Leeford Healthcare Limited
Scimplify
JAMP Pharma Corporation
Actoverco Pharmaceutical Company
CTX Lifesciences Private Limited
DM Pharma
Hema Pharmaceuticals Pvt. Ltd.
Chia-Tai Tianqing Pharmaceutical Group Co. Ltd.
Biophar Lifesciences Pvt. Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
티카그렐러 시장(2029년) : 새로운 기회를 제공하는 국가
티카그렐러 시장(2029년) : 새로운 기회를 제공하는 부문
티카그렐러 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Ticagrelor is an oral antiplatelet drug primarily prescribed to lower the risk of heart attacks, strokes, and other cardiovascular complications in patients with acute coronary syndrome (ACS) or a prior myocardial infarction. It functions by preventing platelet aggregation, which helps reduce the formation of blood clots in the arteries. This enhances blood circulation and decreases the chances of additional cardiovascular incidents.
Ticagrelor is available mainly in two dosage forms: 90 mg and 60 mg tablets. The 90 mg formulation is typically used under prescription to prevent clot formation in individuals diagnosed with acute coronary syndrome or those with a previous heart attack. It falls under multiple therapeutic classes, including antiplatelet and antithrombotic agents. The drug is distributed through various channels such as hospital pharmacies, retail pharmacies, and online platforms. Its primary therapeutic applications include managing acute coronary syndrome, treating myocardial infarction, preventing strokes, and other related conditions. Ticagrelor is used across diverse healthcare settings, including hospitals, clinics, ambulatory care centers, and others.
The ticagrelor market research report is one of a series of new reports from The Business Research Company that provides ticagrelor market statistics, including ticagrelor industry global market size, regional shares, competitors with a ticagrelor market share, detailed ticagrelor market segments, market trends and opportunities, and any further data you may need to thrive in the ticagrelor industry. This ticagrelor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ticagrelor market size has grown strongly in recent years. It will grow from $1.79 billion in 2024 to $1.93 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. This historical growth can be linked to factors such as the rising burden of cardiovascular conditions, an aging global population, increased public awareness regarding heart health, advancements in pharmaceutical R&D, and the growing incidence of acute coronary syndrome.
The Ticagrelor market size is expected to see strong growth in the next few years. It will grow to $2.57 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. Key drivers of this projected growth include the increasing integration of personalized treatment approaches, surging healthcare spending, rising preference for less invasive therapies, a greater emphasis on preventive cardiac care, and supportive governmental cardiac health programs. Notable trends expected during the forecast period include advances in personalized medicine, the emergence of generic ticagrelor products, the use of AI in drug development, innovations in antiplatelet therapy, and the push for improved patient adherence through fixed-dose combination medications.
The rising prevalence of cardiovascular diseases is anticipated to drive the growth of the ticagrelor market in the coming years. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease, heart failure, stroke, and hypertension. This growing prevalence is largely attributed to unhealthy dietary habits, including excessive intake of saturated fats, trans fats, added sugars, and sodium, which contribute to high blood pressure, obesity, and elevated cholesterol levels-key risk factors for heart-related conditions. Ticagrelor plays a crucial role in treating these diseases by preventing platelet aggregation, thereby reducing the risk of blood clots. It enhances patient outcomes by lowering the likelihood of heart attacks and strokes, particularly in high-risk populations. For example, in January 2024, the American Heart Association, a US-based nonprofit organization, reported that the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2022, reflecting a 4.0% rise from 224.4 per 100,000 in 2021. Consequently, the increasing burden of cardiovascular diseases is supporting the expansion of the ticagrelor market.
Key players in the ticagrelor market are actively pursuing regulatory approvals to broaden product indications, improve market penetration, and enhance their competitive standing. Regulatory approvals signify official authorization from governmental bodies to market and distribute a product, ensuring it adheres to established safety, efficacy, and quality standards. For example, in May 2025, Alembic Pharmaceuticals Ltd., an India-based pharmaceutical firm, secured an abbreviated new drug application (ANDA) from the US Food & Drug Administration (USFDA) for its generic ticagrelor tablets in 90 mg strength, along with tentative approval for the 60 mg variant. These tablets are intended to lower the risk of cardiovascular events by inhibiting platelet aggregation and preventing the formation of blood clots.
In May 2023, SERB Pharmaceuticals, a pharmaceutical company based in Luxembourg, entered into a partnership with SFJ Pharmaceuticals Inc. to further the development of a ticagrelor reversal agent. This collaboration aims to support the development, obtain U.S. regulatory approval, and commercialize bentracimab-a reversal agent designed to rapidly neutralize the blood-thinning effects of ticagrelor in patients who require emergency surgery or are experiencing severe bleeding. SFJ Pharmaceuticals Inc. is a U.S.-based pharmaceutical company that specializes in developing ticagrelor reversal agents.
Major players in the ticagrelor market are AstraZeneca PLC, Merck KGaA, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cadila Pharmaceuticals Limited, Alkem Laboratories, Alembic Pharmaceuticals Limited, CCL Pharmaceuticals, Neuland Laboratories, Jiangxi Synergy Pharmaceutical Co. Ltd., Leeford Healthcare Limited, Scimplify, JAMP Pharma Corporation, Actoverco Pharmaceutical Company, CTX Lifesciences Private Limited, DM Pharma, Hema Pharmaceuticals Pvt. Ltd., Chia-Tai Tianqing Pharmaceutical Group Co. Ltd., Biophar Lifesciences Pvt. Ltd., and PhaseBio Pharmaceuticals Inc.
North America was the largest region in the ticagrelor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ticagrelor report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the ticagrelor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ticagrelor market consists of sales of branded oral tablets, generic ticagrelor formulations, fixed-dose combination products, and combination therapies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ticagrelor Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report highlights the rapidly growing ticagrelor market. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for ticagrelor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ticagrelor market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: 90 mg Tablet; 60 mg Tablet
2) By Drug Class: Antiplatelet Agents; Antithrombotic Agents
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
4) By Application: Acute Coronary Syndrome; Myocardial Infarction; Stroke Prevention; Other Applications
5) By End User: Hospitals And Clinics; Ambulatory Centers; Other End Users
Subsegments:
1) By 90 Mg Tablet: Standard 90 Mg Ticagrelor Tablet; Extended-Release 90 Mg Ticagrelor Tablet
2) By 60 Mg Tablet: Standard 60 Mg Ticagrelor Tablet; Extended-Release 60 Mg Ticagrelor Tablet
Companies Mentioned: AstraZeneca PLC; Merck KGaA; Boehringer Ingelheim International GmbH; Sun Pharmaceutical Industries Limited; Dr. Reddy's Laboratories Limited
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Ticagrelor Market Characteristics
3. Ticagrelor Market Trends And Strategies
4. Ticagrelor Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Ticagrelor Growth Analysis And Strategic Analysis Framework
5.1. Global Ticagrelor PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Ticagrelor Market Growth Rate Analysis
5.4. Global Ticagrelor Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Ticagrelor Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Ticagrelor Total Addressable Market (TAM)
6. Ticagrelor Market Segmentation
6.1. Global Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
90 Mg Tablet
60 Mg Tablet
6.2. Global Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antiplatelet Agents
Antithrombotic Agents
6.3. Global Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.4. Global Ticagrelor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Coronary Syndrome
Myocardial Infarction
Stroke Prevention
Other Applications
6.5. Global Ticagrelor Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Ambulatory Centers
Other End Users
6.6. Global Ticagrelor Market, Sub-Segmentation Of 90 Mg Tablet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standard 90 Mg Ticagrelor Tablet
Extended-Release 90 Mg Ticagrelor Tablet
6.7. Global Ticagrelor Market, Sub-Segmentation Of 60 Mg Tablet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standard 60 Mg Ticagrelor Tablet
Extended-Release 60 Mg Ticagrelor Tablet
7. Ticagrelor Market Regional And Country Analysis
7.1. Global Ticagrelor Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Ticagrelor Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Ticagrelor Market
8.1. Asia-Pacific Ticagrelor Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Ticagrelor Market
9.1. China Ticagrelor Market Overview
9.2. China Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Ticagrelor Market
10.1. India Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Ticagrelor Market
11.1. Japan Ticagrelor Market Overview
11.2. Japan Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Ticagrelor Market
12.1. Australia Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Ticagrelor Market
13.1. Indonesia Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Ticagrelor Market
14.1. South Korea Ticagrelor Market Overview
14.2. South Korea Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Ticagrelor Market
15.1. Western Europe Ticagrelor Market Overview
15.2. Western Europe Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Ticagrelor Market
16.1. UK Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Ticagrelor Market
17.1. Germany Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Ticagrelor Market
18.1. France Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Ticagrelor Market
19.1. Italy Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Ticagrelor Market
20.1. Spain Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Ticagrelor Market
21.1. Eastern Europe Ticagrelor Market Overview
21.2. Eastern Europe Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Ticagrelor Market
22.1. Russia Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Ticagrelor Market
23.1. North America Ticagrelor Market Overview
23.2. North America Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Ticagrelor Market
24.1. USA Ticagrelor Market Overview
24.2. USA Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Ticagrelor Market
25.1. Canada Ticagrelor Market Overview
25.2. Canada Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Ticagrelor Market
26.1. South America Ticagrelor Market Overview
26.2. South America Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Ticagrelor Market
27.1. Brazil Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Ticagrelor Market
28.1. Middle East Ticagrelor Market Overview
28.2. Middle East Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Ticagrelor Market
29.1. Africa Ticagrelor Market Overview
29.2. Africa Ticagrelor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Ticagrelor Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Ticagrelor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Ticagrelor Market Competitive Landscape And Company Profiles
30.1. Ticagrelor Market Competitive Landscape
30.2. Ticagrelor Market Company Profiles
30.2.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Dr. Reddy's Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis
31. Ticagrelor Market Other Major And Innovative Companies
31.1. Cadila Pharmaceuticals Limited
31.2. Alkem Laboratories
31.3. Alembic Pharmaceuticals Limited
31.4. CCL Pharmaceuticals
31.5. Neuland Laboratories
31.6. Jiangxi Synergy Pharmaceutical Co. Ltd.
31.7. Leeford Healthcare Limited
31.8. Scimplify
31.9. JAMP Pharma Corporation
31.10. Actoverco Pharmaceutical Company
31.11. CTX Lifesciences Private Limited
31.12. DM Pharma
31.13. Hema Pharmaceuticals Pvt. Ltd.
31.14. Chia-Tai Tianqing Pharmaceutical Group Co. Ltd.
31.15. Biophar Lifesciences Pvt. Ltd.
32. Global Ticagrelor Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Ticagrelor Market
34. Recent Developments In The Ticagrelor Market
35. Ticagrelor Market High Potential Countries, Segments and Strategies
35.1 Ticagrelor Market In 2029 - Countries Offering Most New Opportunities
35.2 Ticagrelor Market In 2029 - Segments Offering Most New Opportunities
35.3 Ticagrelor Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
(주)글로벌인포메이션02-2025-2992kr-info@giikorea.co.kr ⓒ Copyright Global Information, Inc. All rights reserved.
